273 related articles for article (PubMed ID: 27880989)
1. Validation of the prognostic value of histologic scoring systems in primary sclerosing cholangitis: An international cohort study.
de Vries EM; de Krijger M; Färkkilä M; Arola J; Schirmacher P; Gotthardt D; Goeppert B; Trivedi PJ; Hirschfield GM; Ytting H; Vainer B; Buuren HR; Biermann K; Harms MH; Chazouilleres O; Wendum D; Kemgang AD; Chapman RW; Wang LM; Williamson KD; Gouw AS; Paradis V; Sempoux C; Beuers U; Hübscher SG; Verheij J; Ponsioen CY
Hepatology; 2017 Mar; 65(3):907-919. PubMed ID: 27880989
[TBL] [Abstract][Full Text] [Related]
2. Applicability and prognostic value of histologic scoring systems in primary sclerosing cholangitis.
de Vries EM; Verheij J; Hubscher SG; Leeflang MM; Boonstra K; Beuers U; Ponsioen CY
J Hepatol; 2015 Nov; 63(5):1212-9. PubMed ID: 26095184
[TBL] [Abstract][Full Text] [Related]
3. The natural history of primary sclerosing cholangitis in 781 children: A multicenter, international collaboration.
Deneau MR; El-Matary W; Valentino PL; Abdou R; Alqoaer K; Amin M; Amir AZ; Auth M; Bazerbachi F; Broderick A; Chan A; Cotter J; Doan S; El-Youssef M; Ferrari F; Furuya KN; Gottrand M; Gottrand F; Gupta N; Homan M; Kamath BM; Kim KM; Kolho KL; Konidari A; Koot B; Iorio R; Ledder O; Mack C; Martinez M; Miloh T; Mohan P; O'Cathain N; Papadopoulou A; Ricciuto A; Saubermann L; Sathya P; Shteyer E; Smolka V; Tanaka A; Varier R; Venkat V; Vitola B; Vos MB; Woynarowski M; Yap J; Jensen MK
Hepatology; 2017 Aug; 66(2):518-527. PubMed ID: 28390159
[TBL] [Abstract][Full Text] [Related]
4. Collagen proportionate area correlates with histological stage and predicts clinical events in primary sclerosing cholangitis.
Saffioti F; Hall A; de Krijger M; Verheij J; Hübscher SG; Maurice J; Luong TV; Pinzani M; Ponsioen CY; Thorburn D
Liver Int; 2021 Nov; 41(11):2681-2692. PubMed ID: 34051052
[TBL] [Abstract][Full Text] [Related]
5. Enhanced liver fibrosis test predicts transplant-free survival in primary sclerosing cholangitis, a multi-centre study.
de Vries EMG; Färkkilä M; Milkiewicz P; Hov JR; Eksteen B; Thorburn D; Chazouillères O; Pares A; Nygård S; Gilja OH; Wunsch E; Invernizzi P; Carbone M; Bernuzzi F; Boberg KM; Røsjø H; Rosenberg W; Beuers UH; Ponsioen CY; Karlsen TH; Vesterhus M
Liver Int; 2017 Oct; 37(10):1554-1561. PubMed ID: 28267887
[TBL] [Abstract][Full Text] [Related]
6. Recurrent primary sclerosing cholangitis in the Adult-to-Adult Living Donor Liver Transplantation Cohort Study: Comparison of risk factors between living and deceased donor recipients.
Gordon FD; Goldberg DS; Goodrich NP; Lok AS; Verna EC; Selzner N; Stravitz RT; Merion RM
Liver Transpl; 2016 Sep; 22(9):1214-22. PubMed ID: 27339253
[TBL] [Abstract][Full Text] [Related]
7. A novel prognostic model for transplant-free survival in primary sclerosing cholangitis.
de Vries EM; Wang J; Williamson KD; Leeflang MM; Boonstra K; Weersma RK; Beuers U; Chapman RW; Geskus RB; Ponsioen CY
Gut; 2018 Oct; 67(10):1864-1869. PubMed ID: 28739581
[TBL] [Abstract][Full Text] [Related]
8. Patient Age, Sex, and Inflammatory Bowel Disease Phenotype Associate With Course of Primary Sclerosing Cholangitis.
Weismüller TJ; Trivedi PJ; Bergquist A; Imam M; Lenzen H; Ponsioen CY; Holm K; Gotthardt D; Färkkilä MA; Marschall HU; Thorburn D; Weersma RK; Fevery J; Mueller T; Chazouillères O; Schulze K; Lazaridis KN; Almer S; Pereira SP; Levy C; Mason A; Naess S; Bowlus CL; Floreani A; Halilbasic E; Yimam KK; Milkiewicz P; Beuers U; Huynh DK; Pares A; Manser CN; Dalekos GN; Eksteen B; Invernizzi P; Berg CP; Kirchner GI; Sarrazin C; Zimmer V; Fabris L; Braun F; Marzioni M; Juran BD; Said K; Rupp C; Jokelainen K; Benito de Valle M; Saffioti F; Cheung A; Trauner M; Schramm C; Chapman RW; Karlsen TH; Schrumpf E; Strassburg CP; Manns MP; Lindor KD; Hirschfield GM; Hansen BE; Boberg KM;
Gastroenterology; 2017 Jun; 152(8):1975-1984.e8. PubMed ID: 28274849
[TBL] [Abstract][Full Text] [Related]
9. Validation, clinical utility and limitations of the Amsterdam-Oxford model for primary sclerosing cholangitis.
Goet JC; Floreani A; Verhelst X; Cazzagon N; Perini L; Lammers WJ; de Vries AC; van der Meer AJ; van Buuren HR; Hansen BE
J Hepatol; 2019 Nov; 71(5):992-999. PubMed ID: 31278949
[TBL] [Abstract][Full Text] [Related]
10. Secondary sclerosing cholangitis in critically ill patients has a poor outcome but lower tumour incidence than primary sclerosing cholangitis.
Kirstein MM; Book T; Manns MP; von Hahn T; Voigtländer T
United European Gastroenterol J; 2020 Jul; 8(6):716-724. PubMed ID: 32366182
[TBL] [Abstract][Full Text] [Related]
11. Novel histological scoring for predicting disease outcome in primary sclerosing cholangitis.
Sjöblom N; Boyd S; Kautiainen H; Arola J; Färkkilä M
Histopathology; 2022 Aug; 81(2):192-204. PubMed ID: 35510514
[TBL] [Abstract][Full Text] [Related]
12. Baseline values and changes in liver stiffness measured by transient elastography are associated with severity of fibrosis and outcomes of patients with primary sclerosing cholangitis.
Corpechot C; Gaouar F; El Naggar A; Kemgang A; Wendum D; Poupon R; Carrat F; Chazouillères O
Gastroenterology; 2014 Apr; 146(4):970-9; quiz e15-6. PubMed ID: 24389304
[TBL] [Abstract][Full Text] [Related]
13. Liver biopsy in primary biliary cholangitis: is sinusoidal fibrosis the missing key?
Warnes T; Roberts S; Smith A; Haboubi N; McMahon RF
J Clin Pathol; 2019 Oct; 72(10):669-676. PubMed ID: 31371396
[TBL] [Abstract][Full Text] [Related]
14. Primary sclerosing cholangitis. Requiem for biliary drainage operations?
Lemmer ER; Bornman PC; Krige JE; Wright JP; Beningfield S; Jaskiewicz K; Kirsch RE; Kahn D; Terblanche JT; Robson SC
Arch Surg; 1994 Jul; 129(7):723-8. PubMed ID: 8024452
[TBL] [Abstract][Full Text] [Related]
15. Natural history of primary sclerosing cholangitis and prognostic value of cholangiography in a Dutch population.
Ponsioen CY; Vrouenraets SM; Prawirodirdjo W; Rajaram R; Rauws EA; Mulder CJ; Reitsma JB; Heisterkamp SH; Tytgat GN
Gut; 2002 Oct; 51(4):562-6. PubMed ID: 12235081
[TBL] [Abstract][Full Text] [Related]
16. Association between serum IgE level and adverse clinical endpoints in primary sclerosing cholangitis.
Tabibian JH; Enders F; Imam MH; Kolar G; Lindor KD; Talwalkar JA
Ann Hepatol; 2014; 13(3):384-9. PubMed ID: 24756015
[TBL] [Abstract][Full Text] [Related]
17. Predicting clinical and economic outcomes after liver transplantation using the Mayo primary sclerosing cholangitis model and Child-Pugh score. National Institutes of Diabetes and Digestive and Kidney Diseases Liver Transplantation Database Group.
Talwalkar JA; Seaberg E; Kim WR; Wiesner RH
Liver Transpl; 2000 Nov; 6(6):753-8. PubMed ID: 11084063
[TBL] [Abstract][Full Text] [Related]
18. Factors Associated With Outcomes of Patients With Primary Sclerosing Cholangitis and Development and Validation of a Risk Scoring System.
Goode EC; Clark AB; Mells GF; Srivastava B; Spiess K; Gelson WTH; Trivedi PJ; Lynch KD; Castren E; Vesterhus MN; Karlsen TH; Ji SG; Anderson CA; Thorburn D; Hudson M; Heneghan MA; Aldersley MA; Bathgate A; Sandford RN; Alexander GJ; Chapman RW; Walmsley M; ; Hirschfield GM; Rushbrook SM
Hepatology; 2019 May; 69(5):2120-2135. PubMed ID: 30566748
[TBL] [Abstract][Full Text] [Related]
19. No negative impact of serum IgG4 levels on clinical outcome in 435 patients with primary sclerosing cholangitis from Japan.
Tanaka A; Tazuma S; Nakazawa T; Isayama H; Tsuyuguchi T; Inui K; Takikawa H
J Hepatobiliary Pancreat Sci; 2017 Apr; 24(4):217-225. PubMed ID: 28103424
[TBL] [Abstract][Full Text] [Related]
20. Donation after cardiac death liver transplantation in primary sclerosing cholangitis: proceed with caution.
Sundaram V; Choi G; Jeon CY; Ayoub WS; Nissen NN; Klein AS; Tran TT
Transplantation; 2015 May; 99(5):973-8. PubMed ID: 25340598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
